Pataradool K, Korsiyatrakul T: Ovary. Cancer in Thailand 1995–1997. Edited by: Sriplung H, Sontipong S, Martin N, Wiangnon S, Vootiprux V, Cheirsilpa A. 2003, Lyon: IARC, III: 51-52.
Google Scholar
Kritpracha K, Hanprasertpong J, Chandeying V, Dechsukhum C, Geater A: Survival analysis in advanced epithelial ovarian carcinoma in relation to proliferative index of MIB-1 immunostaining. J Obstet Gynaecol Res. 2005, 31: 268-276. 10.1111/j.1447-0756.2005.00270.x.
Article
PubMed
Google Scholar
Smith EM, Anderson B: The effects of symptoms and delay in seeking diagnosis on stage of disease at diagnosis among women with cancers of the ovary. Cancer. 1985, 56: 2727-2732.
Article
CAS
PubMed
Google Scholar
Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics, 1999. CA Cancer J Clin. 1999, 49: 8-31.
Article
CAS
PubMed
Google Scholar
Hartenbach EM, Olson TA, Goswitz JJ, Mohanraj D, Twiggs LB, Carson LF, Ramakrishnan S: Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas. Cancer Lett. 1997, 121: 169-175. 10.1016/S0304-3835(97)00350-9.
Article
CAS
PubMed
Google Scholar
Daponte A, Guidozi F, Tiltman AJ, Marineanu A, Taylor L: p53 as a prognostic factor for stage III serous adenocarcinoma of the ovary. Anticancer Res. 1999, 19: 2387-2389.
CAS
PubMed
Google Scholar
Ikeda K, Sakai K, Yamamoto R, Hareyama H, Tsumura N, Watari H, Shimizu M, Minakami H, Sakuragi N: Multivariate analysis for prognostic significance of histologic subtype, GST-pi, MDR-1, and p53 in stages II–IV ovarian cancer. Int J Gynecol Cancer. 2003, 13: 776-784. 10.1111/j.1525-1438.2003.13381.x.
Article
CAS
PubMed
Google Scholar
Milde-Langosch K, Hagen M, Bamberger AM, Loning T: Expression and prognostic value of the cell-cycle regulatory proteins, Rb, p16MTS1, p21WAF1, p27KIP1, cyclin E, and cyclin D2, in ovarian cancer. Int J Gynecol Pathol. 2003, 22: 168-174. 10.1097/00004347-200304000-00009.
Article
PubMed
Google Scholar
Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, Gosden C, Bard J, Buckler A, Pelletier J, Housman D, van Heyningen V, Hastie N: The candidate Wilms'tumour gene is involved in genitourinary development. Nature. 1990, 346: 194-197. 10.1038/346194a0.
Article
CAS
PubMed
Google Scholar
Scharnhorst V, van der Eb AJ, Jochemsen AG: WT1 proteins: functions in growth and differentiation. Gene. 2001, 273: 141-161. 10.1016/S0378-1119(01)00593-5.
Article
CAS
PubMed
Google Scholar
Buckler AJ, Pelletier J, Haber DA, Glaser T, Housman DE: Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development. Mol Cell Biol. 1991, 11: 1707-1712.
Article
CAS
PubMed
PubMed Central
Google Scholar
Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H, Kita K, Hiraoka A, Masaoka T, Nasu K, Kyo T, Dohy H, Nakauchi H, Ishidate T, Akiyama T, Kishimoto T: WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood. 1994, 84: 3071-3079.
CAS
PubMed
Google Scholar
Bergmann L, Miething C, Maurer U, Brieger J, Karakas T, Weidmann E, Hoelzer D: High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood . 1997, 90: 1217-1225.
CAS
PubMed
Google Scholar
Ghanem MA, Van der Kwast TH, Den Hollander JC, Sudaryo MK, Oomen MH, Noordzij MA, Van den Heuvel MM, Nassef SM, Nijman RM, Van Steenbrugge GJ: Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma. Clin Cancer Res. 2000, 6: 4265-4271.
CAS
PubMed
Google Scholar
Miyoshi Y, Ando A, Egawa C, Taguchi T, Tamaki Y, Tamaki H, Sugiyama H, Noguchi S: High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients. Clin Cancer Res. 2002, 8: 1167-1171.
CAS
PubMed
Google Scholar
Shimizu M, Toki T, Takagi Y, Konishi I, Fujii S: Immunohistochemical detection of the Wilms' tumor gene (WT1) in epithelial ovarian tumors. Int J Gynecol Pathol. 2000, 19: 158-163. 10.1097/00004347-200004000-00010.
Article
CAS
PubMed
Google Scholar
Berek JS: Ovarian cancer. Novak's Textbook of Gynecology. Edited by: Berek JS. 2002, Baltimore: William and Wilkins, 1245-1319. 13
Google Scholar
Goldstein NS, Bassi D, Uzieblo A: WT1 is an integral component of an antibody panel to distinguish pancreaticobiliary and some ovarian epithelial neoplasms. Am J Clin Pathol. 2001, 116: 246-252. 10.1309/8X4T-35B7-7529-QE7X.
Article
CAS
PubMed
Google Scholar
Hwang H, Quenneville L, Yaziji H, Gown AM: Wilms tumor gene product: sensitive and contextually specific marker of serous carcinomas of ovarian surface epithelial origin. Appl Immunohistochem Mol Morphol. 2004, 12: 122-126.
Article
PubMed
Google Scholar
WHO: Handbook for reporting results of cancer treatment. 1979, Geneva, Switzerland: World Health Orgenization, 48-
Google Scholar
Schorge JO, Miller YB, Qi LJ, Muto MG, Welch WR, Berkowitz RS, Mok SC: Genetic alterations of the WT1 gene in papillary serous carcinoma of the peritoneum. Gynecol Oncol. 2000, 76: 369-372. 10.1006/gyno.1999.5711.
Article
CAS
PubMed
Google Scholar
Cohen HT, Bossone SA, Zhu G, McDonald GA, Sukhatme VP: Sp1 is a critical regulator of the Wilms' tumor-1 gene. J Biol Chem. 1997, 272: 2901-2913. 10.1074/jbc.272.11.7151.
Article
CAS
PubMed
Google Scholar
McConnell MJ, Cunliffe HE, Chua LJ, Ward TA, Eccles MR: Differential regulation of the human Wilms tumour suppressor gene (WT1) promoter by two isoforms of PAX2. Oncogene. 1997, 14: 2689-2700. 10.1038/sj.onc.1201114.
Article
CAS
PubMed
Google Scholar
Fraizer GC, Shimamura R, Zhang X, Saunders GF: PAX 8 regulates human WT1 transcription through a novel DNA binding site. J Biol Chem. 1997, 272: 30678-30687. 10.1074/jbc.272.49.30678.
Article
CAS
PubMed
Google Scholar
Dehbi M, Pelletier J: PAX8-mediated activation of the wt1 tumor suppressor gene. EMBO J. 1996, 15: 4297-4306.
CAS
PubMed
PubMed Central
Google Scholar
Discenza MT, Vaz D, Hassell JA, Pelletier J: Activation of the WT1 tumor suppressor gene promoter by Pea3. FEBS Lett. 2004, 560: 183-191. 10.1016/S0014-5793(04)00104-8.
Article
CAS
PubMed
Google Scholar
Maheswaran S, Englert C, Bennett P, Heinrich G, Haber DA: The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes Dev. 1995, 9: 2143-2156.
Article
CAS
PubMed
Google Scholar
Johnstone RW, See RH, Sells SF, Wang J, Muthukkumar S, Englert C, Haber DA, Licht JD, Sugrue SP, Roberts T, Rangnekar VM, Shi Y: A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1. Mol Cell Biol. 1996, 16: 6945-6956.
Article
CAS
PubMed
PubMed Central
Google Scholar
Silberstein GB, Van Horn K, Strickland P, Roberts CT, Daniel CW: Altered expression of the WT1 wilms tumor suppressor gene in human breast cancer. Proc Natl Acad Sci U S A. 1997, 94: 8132-8137. 10.1073/pnas.94.15.8132.
Article
CAS
PubMed
PubMed Central
Google Scholar
Garg M, Moore H, Tobal K, Liu Yin JA: Prognostic significance of quantitative analysis of WT1 gene transcripts by competitive reverse transcription polymerase chain reaction in acute leukaemia. Br J Haematol. 2003, 123: 49-59. 10.1046/j.1365-2141.2003.04552.x.
Article
CAS
PubMed
Google Scholar
Hylander B, Repasky E, Shrikant P, Intengan M, Beck A, Driscoll D, Singhal P, Lele S, Odunsi K: Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer. Gynecol Oncol. 2006, 101: 12-17. 10.1016/j.ygyno.2005.09.052.
Article
CAS
PubMed
Google Scholar
Oji Y, Ogawa H, Tamaki H, Oka Y, Tsuboi A, Kim EH, Soma T, Tatekawa T, Kawakami M, Asada M, Kishimoto T, Sugiyama H: Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth. Jpn J Cancer Res. 1999, 90: 194-204.
Article
CAS
PubMed
Google Scholar
Omura GA, Brady MF, Homesley HD, Yordan E, Major FJ, Buchsbaum HJ, Park RC: Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma:the Gynecologic Oncology Group experience. J Clin Oncol. 1991, 9: 1138-1150.
CAS
PubMed
Google Scholar
Brinkhuis M, Meijer GA, Baak JP: An evaluation of prognostic factors in advanced ovarian cancer. Eur J Obstet Gynecol Reprod Biol. 1995, 63: 115-124. 10.1016/0301-2115(95)02211-2.
Article
CAS
PubMed
Google Scholar